Literature DB >> 9291125

Inhibition of intracellular proteolytic processing of soluble proproteins by an engineered alpha 2-macroglobulin containing a furin recognition sequence in the bait region.

L Van Rompaey1, T Ayoubi, W Van De Ven, P Marynen.   

Abstract

The bait region of the general protease inhibitor alpha 2-macroglobulin (alpha 2M) was mutated by introducing a recognition sequence of furin. This did not interfere with folding, S-ester formation or tetramerization of the mutant recombinant alpha 2M (r alpha 2M). Mutant r alpha 2M inhibited furin in vitro, by a similar mechanism to that used by plasma alpha 2M to inhibit high-molecular-mass proteases. The mutant alpha 2M was intracellularly active in COS-1 cells in inhibiting the endogenous processing of the soluble substrates for furin (von Willebrand factor, transforming growth factor beta1 and a soluble form of the envelope glycoprotein gp160 from HIV-1) but not the membrane-bound form of gp160. The intracellular activity of mutant alpha 2M strongly indicated that alpha 2M attains its native conformation, and thus that the unusual internal S-ester is formed, before alpha 2M passes through the cleavage compartment(s). Our results show for the first time that modulation of the bait region of alpha 2M allows the creation of an inhibitor against membrane-bound proteases. It can be expected that the use of alpha 2M-bait mutants will become important as a technique for the study of various proteolytic processes and for the identification of the proteases involved.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9291125      PMCID: PMC1218698          DOI: 10.1042/bj3260507

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  63 in total

1.  A thiol-ester in alpha 2-macroglobulin cleaved during proteinase complex formation.

Authors:  L Sottrup-Jensen; T E Petersen; S Magnusson
Journal:  FEBS Lett       Date:  1980-12-01       Impact factor: 4.124

2.  A monoclonal antibody to a neo-antigen on alpha 2-macroglobulin complexes inhibits receptor-mediated endocytosis.

Authors:  P Marynen; F Van Leuven; J J Cassiman; H Van den Berghe
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

3.  Primary and secondary cleavage sites in the bait region of alpha 2-macroglobulin.

Authors:  S B Mortensen; L Sottrup-Jensen; H F Hansen; T E Petersen; S Magnusson
Journal:  FEBS Lett       Date:  1981-12-07       Impact factor: 4.124

4.  Post-translational modification of the fourth component of complement. Effect of tunicamycin and amino acid analogs on the formation of the internal thiol ester and disulfide bonds.

Authors:  D R Karp
Journal:  J Biol Chem       Date:  1983-12-10       Impact factor: 5.157

5.  Thrombin-induced conformational changes of human alpha 2-macroglobulin: evidence for two functional domains.

Authors:  J P Steiner; P Bhattacharya; D K Strickland
Journal:  Biochemistry       Date:  1985-06-04       Impact factor: 3.162

6.  Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells.

Authors:  R Derynck; J A Jarrett; E Y Chen; D H Eaton; J R Bell; R K Assoian; A B Roberts; M B Sporn; D V Goeddel
Journal:  Nature       Date:  1985 Aug 22-28       Impact factor: 49.962

7.  Characterization of thrombin binding to alpha 2-macroglobulin.

Authors:  D L Straight; P A McKee
Journal:  J Biol Chem       Date:  1984-01-25       Impact factor: 5.157

8.  The interaction of alpha 2-macroglobulin with proteinases. Characteristics and specificity of the reaction, and a hypothesis concerning its molecular mechanism.

Authors:  A J Barrett; P M Starkey
Journal:  Biochem J       Date:  1973-08       Impact factor: 3.857

9.  Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160.

Authors:  S Hallenberger; V Bosch; H Angliker; E Shaw; H D Klenk; W Garten
Journal:  Nature       Date:  1992-11-26       Impact factor: 49.962

10.  Full-length von Willebrand factor (vWF) cDNA encodes a highly repetitive protein considerably larger than the mature vWF subunit.

Authors:  C L Verweij; P J Diergaarde; M Hart; H Pannekoek
Journal:  EMBO J       Date:  1986-08       Impact factor: 11.598

View more
  13 in total

1.  A protein-based therapeutic for human cytomegalovirus infection.

Authors:  F Jean; L Thomas; S S Molloy; G Liu; M A Jarvis; J A Nelson; G Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

2.  Endoproteolytic processing of integrin pro-alpha subunits involves the redundant function of furin and proprotein convertase (PC) 5A, but not paired basic amino acid converting enzyme (PACE) 4, PC5B or PC7.

Authors:  J C Lissitzky; J Luis; J S Munzer; S Benjannet; F Parat; M Chrétien; J Marvaldi; N G Seidah
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

3.  Identification of serpin determinants of specificity and selectivity for furin inhibition through studies of α1PDX (α1-protease inhibitor Portland)-serpin B8 and furin active-site loop chimeras.

Authors:  Gonzalo Izaguirre; Lixin Qi; Mary Lima; Steven T Olson
Journal:  J Biol Chem       Date:  2013-06-06       Impact factor: 5.157

4.  Synthetic small molecule furin inhibitors derived from 2,5-dideoxystreptamine.

Authors:  Guan-Sheng Jiao; Lynne Cregar; Jinzhi Wang; Sherri Z Millis; Cho Tang; Sean O'Malley; Alan T Johnson; Sina Sareth; Jason Larson; Gary Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-18       Impact factor: 11.205

Review 5.  Inhibitors of proprotein convertases.

Authors:  Ajoy Basak
Journal:  J Mol Med (Berl)       Date:  2005-10-08       Impact factor: 4.599

6.  Effect of alpha-1 antitrypsin Portland variant (alpha 1-PDX) on HIV-1 replication.

Authors:  B Bahbouhi; M Bendjennat; D Guétard; N G Seidah; E Bahraoui
Journal:  Biochem J       Date:  2000-11-15       Impact factor: 3.857

Review 7.  Proprotein convertases in tumor progression and malignancy: novel targets in cancer therapy.

Authors:  Abdel-Majid Khatib; Géraldine Siegfried; Michel Chrétien; Peter Metrakos; Nabil G Seidah
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

8.  Generation and characterization of non-competitive furin-inhibiting nanobodies.

Authors:  Jingjing Zhu; Jeroen Declercq; Bart Roucourt; Gholamreza H Ghassabeh; Sandra Meulemans; Jörg Kinne; Guido David; Alphons J M Vermorken; Wim J M Van de Ven; Iris Lindberg; Serge Muyldermans; John W M Creemers
Journal:  Biochem J       Date:  2012-11-15       Impact factor: 3.857

Review 9.  HIV envelope: challenges and opportunities for development of entry inhibitors.

Authors:  Michael Caffrey
Journal:  Trends Microbiol       Date:  2011-03-04       Impact factor: 17.079

10.  alpha1-Antitrypsin Portland, a bioengineered serpin highly selective for furin: application as an antipathogenic agent.

Authors:  F Jean; K Stella; L Thomas; G Liu; Y Xiang; A J Reason; G Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 12.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.